Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
98
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer

Liang Huang1 Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
,
Qi Liu2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;3 Department of Radiation Oncology, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, China
,
Sheng Chen1 Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
&
Zhiming Shao1 Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaCorrespondence[email protected]
Pages 5739-5744 | Published online: 01 Dec 2017

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lakshmi Kumari, Lopamudra Mishra, Preeti Patel, Nitin Sharma, Ghanshyam Das Gupta & Balak Das Kurmi. (2023) Emerging targeted therapeutic strategies for the treatment of triple-negative breast cancer. Journal of Drug Targeting 31:9, pages 889-907.
Read now

Articles from other publishers (13)

Ragini Singh, Shuang Cheng, Qinghua Zeng, Santosh Kumar & Carlos Marques. (2022) Synergistic Anti-Tumor Effect of Palmitoylcarnitine and Dasatinib in Liver Cancer. Livers 2:4, pages 344-360.
Crossref
Neha Pathak, Aparna Sharma, Arunmozhimaran Elavarasi, Jeeva Sankar, S.V.S. Deo, Daya N. Sharma, Sandeep Mathur, Sudhir Kumar, Chandra P. Prasad, Akash Kumar & Atul Batra. (2022) Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis. The Breast 64, pages 7-18.
Crossref
Yu Jiang, Baozhi Song & Zhiqin Chen. (2022) Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis. Computational and Mathematical Methods in Medicine 2022, pages 1-8.
Crossref
Reyhaneh Farghadani & Rakesh Naidu. (2022) Curcumin as an Enhancer of Therapeutic Efficiency of Chemotherapy Drugs in Breast Cancer. International Journal of Molecular Sciences 23:4, pages 2144.
Crossref
Vandana Singh, Kuldeep Kumar, Deepika Purohit, Ravinder Verma, Parijat Pandey, Saurabh Bhatia, Vinay Malik, Vineet Mittal, Md. Habibur Rahman, Ghadeer M. Albadrani, Mohammed W. Arafah, Fatma M. El-Demerdash, Muhammad Furqan Akhtar, Ammara Saleem, Mohamed Kamel, Agnieszka Najda, Mohamed M. Abdel-Daim & Deepak Kaushik. (2021) Exploration of therapeutic applicability and different signaling mechanism of various phytopharmacological agents for treatment of breast cancer. Biomedicine & Pharmacotherapy 139, pages 111584.
Crossref
Anna Wawruszak, Jarogniew Luszczki, Marta Halasa, Estera Okon, Sebastian Landor, Cecilia Sahlgren, Adolfo Rivero-Muller & Andrzej Stepulak. (2021) Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together. International Journal of Molecular Sciences 22:10, pages 5184.
Crossref
Fei Lu, Yu Hou, Zhengting Chen, Jie Jiang, Xi He, Yaoxiong Xia, Ke Cao, Li Chang & Wenhui Li. (2021) Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials. Technology in Cancer Research & Treatment 20, pages 153303382110163.
Crossref
Jenny Furlanetto & Sibylle Loibl. (2020) Optimal Systemic Treatment for Early Triple-Negative Breast Cancer. Breast Care 15:3, pages 217-226.
Crossref
S. Priya & P.K. Satheeshkumar. 2020. Functional and Preservative Properties of Phytochemicals. Functional and Preservative Properties of Phytochemicals 145 163 .
Lifang Yang, Xuemei Qin, Hongcun Liu, Yanye Wei, Hailiang Zhu & Mingguo Jiang. (2019) Design, synthesis and biological evaluation of a series of new resveratrol analogues as potential anti-cancer agents. Royal Society Open Science 6:9, pages 190125.
Crossref
Gang Liu, Tao Yin, Hyejin Kim, Chunyong Ding, Zhuo Yu, Hong Wang, Haiying Chen, Ruping Yan, Eric A. Wold, Hao Zou, Xi Liu, Ye Ding, Qiang Shen & Jia Zhou. (2019) Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer. European Journal of Medicinal Chemistry 178, pages 589-605.
Crossref
Anna Wawruszak, Jarogniew J. Luszczki, Joanna Kalafut, Karolina Okla, Marta Halasa, Adolfo Rivero-Muller & Andrzej Stepulak. (2019) Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis. International Journal of Molecular Sciences 20:15, pages 3663.
Crossref
Pouria Samadi, Sahar Saki, Fatemeh Karimi Dermani, Mona Pourjafar & Massoud Saidijam. (2018) Emerging ways to treat breast cancer: will promises be met?. Cellular Oncology 41:6, pages 605-621.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.